|Posted:||January 3, 2019 12:42 PM|
|From:||Representative Marty Flynn|
|To:||All House members|
|Subject:||Urging the FDA to Consider Lyme Disease Vaccinations|
|Lyme disease is one of the most commonly reported tick-borne illnesses in the United States, affecting approximately 329,000 individuals each year. Pennsylvania is specifically impacted by this condition, as cases of Lyme disease in our state increased by nearly 50% between 2013 and 2017. While early-stage Lyme disease may be treated, undiagnosed or untreated Lyme disease can cause long-term joint inflammation and heart rhythm problems, among other complications. Although a vaccine was previously available to the public, it was taken off of the market due to declining sales and fears of potential side effects.
In an effort to prevent the spread of Lyme disease further, I am introducing a resolution urging the United States Food and Drug Administration (FDA) to promptly consider candidates for Lyme disease vaccinations that are currently undergoing the drug approval process. It is my hope that my measure will expedite the approval of a Lyme disease vaccine.
Please join me in co-sponsoring this resolution in an attempt to address the alarming rise of Lyme disease in this Commonwealth.
Introduced as HR89